What does the CTSO options chain show right now?

As of May 15, 2026, Cytosorbents Corporation (CTSO) has 153 contracts outstanding and 0 traded today, with ATM IV of 32.1%. The full chain spans every listed strike and expiration with bid/ask, Greeks, volume, and open interest per contract.

What expirations are available for CTSO options?

The nearest expiration is 34 days out, followed by 63 days. Listed expirations typically extend monthly with weeklies between, plus LEAPS one to two years out for liquid names.

How tight are CTSO options bid/ask spreads?

Average bid/ask spread across the chain is 28.74%. Wider spreads warrant conservative sizing; mid-market fills are unreliable for retail-size orders.

Cytosorbents Corporation (CTSO) Options Chain

The options chain displays all available contracts with real-time quotes, Greeks, volume, and open interest for each strike and expiration. It is the primary tool for options trade selection.

Cytosorbents Corporation (CTSO) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $35.8M, listed on NASDAQ, employing roughly 149 people, carrying a beta of 1.44 to the broader market. Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Led by Phillip Chan, public since 2006-08-08.

Snapshot as of May 15, 2026.

Spot Price: $0.50
Total OI: 153
Total Volume: 0
Front Expiration: 34 days
Second Expiration: 63 days
ATM IV: 32.1%
Avg Bid/Ask Spread: 28.74%

As of May 15, 2026, Cytosorbents Corporation (CTSO) has 153 open contracts and 0 contracts traded. The nearest expiration is 34 days out, followed by 63 days. ATM implied volatility is 32.1%. Average bid/ask spread across the chain is 28.74%: wider spreads, size positions conservatively. The options chain aggregates every listed strike and expiration, letting traders evaluate skew, term structure, and liquidity in a single view.

How CTSO options chain Data Feeds Strategy Selection

Strategy selection on Cytosorbents Corporation options does not derive from any single metric in isolation. The options chain view above sits inside a broader read: ATM IV currently sits at 32.1% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the options chain data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.

Learn how the options chain is reported and how to read the data →

Frequently asked CTSO options chain questions

What does the CTSO options chain show right now?: As of May 15, 2026, Cytosorbents Corporation (CTSO) has 153 contracts outstanding and 0 traded today, with ATM IV of 32.1%. The full chain spans every listed strike and expiration with bid/ask, Greeks, volume, and open interest per contract.
What expirations are available for CTSO options?: The nearest expiration is 34 days out, followed by 63 days. Listed expirations typically extend monthly with weeklies between, plus LEAPS one to two years out for liquid names.
How tight are CTSO options bid/ask spreads?: Average bid/ask spread across the chain is 28.74%. Wider spreads warrant conservative sizing; mid-market fills are unreliable for retail-size orders.